|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
EP2099826B1
(en)
*
|
2007-01-05 |
2013-10-16 |
University Of Zurich |
Anti-beta-amyloid antibody and uses thereof
|
|
EP2210901A4
(en)
*
|
2007-10-19 |
2012-04-25 |
Immunas Pharma Inc |
FOR THE SPECIFIC BINDING TO AN OLIGOMICALLY ABLE ANTIBODY AND ITS USE
|
|
EP3121277B1
(en)
|
2008-02-08 |
2018-04-11 |
Immunas Pharma, Inc. |
Antibody capable of binding specifically to ab-oligomer, and use thereof
|
|
US20110182809A1
(en)
*
|
2008-07-09 |
2011-07-28 |
University Of Zurich |
Method of Promoting Neurogenesis
|
|
EP3521309A1
(en)
|
2008-12-19 |
2019-08-07 |
Biogen International Neuroscience GmbH |
Human anti-alpha-synuclein antibodies
|
|
WO2010119704A1
(en)
|
2009-04-17 |
2010-10-21 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
US8613924B2
(en)
|
2009-08-06 |
2013-12-24 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to A beta oligomers and use thereof
|
|
TWI672318B
(zh)
|
2010-02-24 |
2019-09-21 |
美商免疫遺傳股份有限公司 |
葉酸受體１抗體類和免疫共軛物類及彼等之用途
|
|
JP2014505057A
(ja)
|
2011-01-10 |
2014-02-27 |
ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン |
幹細胞因子阻害剤
|
|
EP3252076B1
(en)
|
2011-01-14 |
2019-09-04 |
The Regents Of The University Of California |
Diagnostic use of antibodies against ror-1 protein
|
|
CN114441757A
(zh)
|
2011-04-01 |
2022-05-06 |
伊缪诺金公司 |
用于增加folr1癌症治疗的功效的方法
|
|
MX357193B
(es)
|
2011-06-23 |
2018-06-29 |
Univ Zuerich |
Moleculas de union anti-alfa sinucleina.
|
|
GB201110938D0
(en)
*
|
2011-06-27 |
2011-08-10 |
Iti Scotland Ltd |
Compounds
|
|
US20140377288A1
(en)
*
|
2011-09-16 |
2014-12-25 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to dna damage repair
|
|
PL2890717T3
(pl)
|
2012-08-31 |
2020-08-10 |
Immunogen, Inc. |
Testy i zestawy diagnostyczne do wykrywania receptora folianu
|
|
WO2014100439A2
(en)
*
|
2012-12-19 |
2014-06-26 |
Amplimmune, Inc. |
B7-h4 specific antibodies, and compositions and methods of use thereof
|
|
US9534044B2
(en)
*
|
2013-02-28 |
2017-01-03 |
United Arab Emirates University |
Alpha-synuclein antibodies and uses thereof
|
|
WO2015006554A1
(en)
*
|
2013-07-10 |
2015-01-15 |
The Regents Of The University Of Michigan |
Therapeutic antibodies and uses thereof
|
|
WO2015027120A1
(en)
*
|
2013-08-21 |
2015-02-26 |
Jiang Jean X |
Compositions and methods for targeting connexin hemichannels
|
|
CN105814079B
(zh)
|
2013-08-30 |
2021-02-09 |
伊缪诺金公司 |
用于检测叶酸受体1的抗体和测定
|
|
WO2015054600A2
(en)
*
|
2013-10-10 |
2015-04-16 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
CA2924520C
(en)
*
|
2013-11-01 |
2023-09-26 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
|
|
CA2938152A1
(en)
*
|
2014-02-10 |
2015-08-13 |
Merck Sharp & Dohme Corp. |
Antibodies that bind to human tau and assay for quantifying human tau using the antibodies
|
|
US10401368B2
(en)
|
2014-03-20 |
2019-09-03 |
Pdl Biopharma, Inc. |
Antibodies and methods for the detection of cell death
|
|
EP3662928A1
(en)
*
|
2014-04-10 |
2020-06-10 |
OBI Pharma Inc. |
Antibodies binding to tumour associated carbohydrate antigens, pharmaceutical compositions and uses thereof
|
|
MY198017A
(en)
|
2014-08-19 |
2023-07-26 |
Merck Sharp & Dohme |
Anti-tigit antibodies
|
|
KR20170056521A
(ko)
|
2014-09-16 |
2017-05-23 |
오바사이언스, 인크. |
항-vasa 항체, 및 이것의 제조 및 사용 방법
|
|
JP2017536102A
(ja)
*
|
2014-10-16 |
2017-12-07 |
ジェネンテック， インコーポレイテッド |
抗アルファ−シヌクレイン抗体及び使用方法
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
EP4183806A3
(en)
|
2014-11-12 |
2023-08-02 |
Seagen Inc. |
Glycan-interacting compounds and methods of use
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
CA2971517A1
(en)
*
|
2014-12-19 |
2016-06-23 |
Universite De Nantes |
Anti il-34 antibodies
|
|
US10654917B2
(en)
*
|
2015-01-29 |
2020-05-19 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
|
WO2016137947A1
(en)
*
|
2015-02-24 |
2016-09-01 |
Rpeptide, Llc |
Anti-amyloid-beta antibodies
|
|
WO2016145022A1
(en)
*
|
2015-03-11 |
2016-09-15 |
The Board Of Regents Of The University Of Texas System |
Anti-dc-hil antibodies for cancer diagnosis, prognosis and therapy
|
|
WO2016149116A1
(en)
*
|
2015-03-13 |
2016-09-22 |
University Of Maryland, Baltimore |
Antibodies targeting s100b and methods of use
|
|
WO2016160618A2
(en)
*
|
2015-03-27 |
2016-10-06 |
University Of Southern California |
Car t-cell therapy directed to lhr for the treatment of solid tumors
|
|
EP3307784B1
(en)
*
|
2015-06-10 |
2021-12-22 |
National Research Council of Canada |
Carbonic anhydrase ix-specific antibodies and uses thereof
|
|
WO2016205566A1
(en)
*
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
WO2017030823A2
(en)
*
|
2015-08-14 |
2017-02-23 |
Merck Sharp & Dohme Corp. |
Anti-tigit antibodies
|
|
RU2021133819A
(ru)
*
|
2015-09-02 |
2021-12-10 |
Иммутеп С.A.С. |
Анти-lag-3 антитела
|
|
KR102700777B1
(ko)
|
2015-09-17 |
2024-08-29 |
이뮤노젠 아이엔씨 |
항-folr1 면역접합체를 포함하는 치료제 조합
|
|
HK1259325A1
(zh)
|
2015-11-09 |
2019-11-29 |
英属哥伦比亚大学 |
淀粉样蛋白β中的N-末端表位及其构象选择性抗体
|
|
CN108350052A
(zh)
|
2015-11-09 |
2018-07-31 |
英属哥伦比亚大学 |
淀粉样蛋白β中间区域中的表位及其构象选择性抗体
|
|
KR20180094876A
(ko)
|
2015-11-09 |
2018-08-24 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타 에피토프 및 이에 대한 항체
|
|
CN108463248B
(zh)
|
2015-11-12 |
2022-10-21 |
西雅图基因公司 |
聚糖相互作用化合物及使用方法
|
|
US10537633B2
(en)
|
2016-03-04 |
2020-01-21 |
Jn Biosciences Llc |
Antibodies to TIGIT
|
|
AU2017234528B2
(en)
*
|
2016-03-16 |
2023-09-28 |
Nathan Bartlett |
Neutralizing monoclonal antibodies to IL-25 and uses thereof
|
|
US20180362660A1
(en)
*
|
2016-05-09 |
2018-12-20 |
Schickwann Tsai |
Anti-penumbra monoclonal antibodies for detection and therapy of normal and abnormal B lymphocytes
|
|
US10815306B2
(en)
|
2016-06-16 |
2020-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Humanized and chimeric monoclonal antibodies to CD81
|
|
US12071472B2
(en)
|
2016-07-18 |
2024-08-27 |
The University Of British Columbia |
Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers
|
|
JOP20170154B1
(ar)
*
|
2016-08-01 |
2023-03-28 |
Omeros Corp |
تركيبات وطرق لتثبيط masp-3 لعلاج أمراض واضطرابات مختلفة
|
|
TW201827467A
(zh)
*
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
WO2018094143A1
(en)
|
2016-11-17 |
2018-05-24 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
WO2018098370A1
(en)
*
|
2016-11-23 |
2018-05-31 |
Immunoah Therapeutics, Inc. |
4-1bb binding proteins and uses thereof
|
|
CN106749657A
(zh)
*
|
2016-12-13 |
2017-05-31 |
中国农业科学院哈尔滨兽医研究所 |
一种抗体信号肽及其应用
|
|
US11458169B2
(en)
|
2017-02-22 |
2022-10-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
TIM3-binding chimeric antigen receptors
|
|
WO2018158398A1
(en)
*
|
2017-03-02 |
2018-09-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to nectin-4 and uses thereof
|
|
WO2018160909A1
(en)
|
2017-03-03 |
2018-09-07 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
EP3608335A4
(en)
*
|
2017-04-05 |
2020-04-29 |
XDCExplorer (Shanghai) Co., Ltd. |
HUMANIZED ANTI-TPBG ANTIBODY, PRODUCTION METHOD THEREFOR, CONJUGATE THEREOF AND APPLICATIONS
|
|
US11161897B2
(en)
*
|
2017-07-17 |
2021-11-02 |
Janssen Biotech, Inc. |
Antigen binding regions against fibronectin type III domains and methods of using the same
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
JP7368856B2
(ja)
|
2017-07-25 |
2023-10-25 |
トゥルーバインディング，インコーポレイテッド |
Ｔｉｍ－３とそのリガンドとの相互作用の遮断によるがん治療
|
|
EP4233901A3
(en)
|
2017-08-22 |
2023-09-06 |
Biogen MA Inc. |
Pharmaceutical compositions containing anti-beta amyloid antibodies
|
|
WO2019217833A1
(en)
*
|
2018-05-10 |
2019-11-14 |
Abvision, Inc. |
Monoclonal antibodies activating cd40 and uses thereof
|
|
WO2019231957A1
(en)
*
|
2018-05-30 |
2019-12-05 |
National Health Research Institutes |
Anti-abeta antibodies and uses thereof
|
|
US12060419B2
(en)
|
2018-06-14 |
2024-08-13 |
Regeneron Pharmaceuticals, Inc. |
CD79A chimeric antigen receptors
|
|
JP7623939B2
(ja)
*
|
2018-07-09 |
2025-01-29 |
マルチチュード インコーポレーテッド |
葉酸受容体アルファに特異的な抗体
|
|
EP3852779A4
(en)
*
|
2018-09-17 |
2022-06-08 |
Abcuro, Inc. |
ANTI-KLRG1 ANTIBODIES
|
|
JP2022523502A
(ja)
*
|
2019-01-29 |
2022-04-25 |
シャンハイ ジャオ トン ユニバーシティ |
キメラ抗原受容体およびその使用
|
|
CN120058944A
(zh)
|
2019-01-30 |
2025-05-30 |
真和制药有限公司 |
抗gal3抗体及其用途
|
|
CN113784983B
(zh)
*
|
2019-03-02 |
2024-04-16 |
小利兰·斯坦福大学托管委员会 |
Cd93特异性治疗性抗原结合蛋白及其使用方法
|
|
WO2020193644A1
(en)
|
2019-03-26 |
2020-10-01 |
Janssen Pharmaceutica Nv |
ANTIBODIES TO PYROGLUTAMATE AMYLOID-ß AND USES THEREOF
|
|
CN110343180B
(zh)
*
|
2019-07-25 |
2021-03-30 |
北京免疫方舟医药科技有限公司 |
抗ctla-4抗体及其应用
|
|
US12352719B2
(en)
|
2019-09-20 |
2025-07-08 |
KYCERA AVX Components Corporation |
Somatic cell-based electrical biosensor
|
|
CN111793136A
(zh)
*
|
2020-05-11 |
2020-10-20 |
廊坊天光生物技术有限公司 |
一种nmp22抗体对及其应用
|
|
CN111808191A
(zh)
*
|
2020-05-11 |
2020-10-23 |
廊坊天光生物技术有限公司 |
一种用于检测血清中vegf含量的抗体对及其用途
|
|
US20230340089A1
(en)
*
|
2020-05-14 |
2023-10-26 |
City Of Hope |
Smc1a antibodies and uses thereof
|
|
JP2023528797A
(ja)
|
2020-05-26 |
2023-07-06 |
トゥルーバインディング，インコーポレイテッド |
ガレクチン－３を遮断することにより炎症性疾患を処置する方法
|
|
CR20220611A
(es)
|
2020-06-02 |
2023-06-07 |
Arcus Biosciences Inc |
Anticuerpos anti-tigit
|
|
US20230265175A1
(en)
|
2020-06-25 |
2023-08-24 |
Merck Sharp & Dohme Llc |
High affinity antibodies targeting tau phosphorylated at serine 413
|
|
MX2023000949A
(es)
|
2020-07-23 |
2023-02-22 |
Othair Prothena Ltd |
Anticuerpos anti-beta-amiloide (abeta).
|
|
JP2023536629A
(ja)
*
|
2020-08-04 |
2023-08-28 |
エグゼリクシス， インコーポレイテッド |
Ｃｄ４７結合性作用剤およびその使用
|
|
KR20230047492A
(ko)
*
|
2020-08-18 |
2023-04-07 |
오메로스 코포레이션 |
보체 인자 d의 검출을 위한 단클론성 항체, 조성물 및 방법
|
|
CN112778419A
(zh)
*
|
2021-02-01 |
2021-05-11 |
重庆中元汇吉生物技术有限公司 |
抗ck-mb的抗体或其抗原结合部分及其应用
|
|
US20240117047A1
(en)
*
|
2021-02-11 |
2024-04-11 |
The Regents Of The University Of California |
Monoclonal antibodies specific for human ror1
|
|
CN113075398A
(zh)
*
|
2021-03-23 |
2021-07-06 |
中国医学科学院输血研究所 |
一种血浆中特异性IgG抗体的定量测定方法
|
|
WO2023076926A1
(en)
*
|
2021-10-26 |
2023-05-04 |
Bach Diagnostics Inc. |
Lateral flow assay for the diagnosis of dermatmycoses
|
|
KR20250102074A
(ko)
*
|
2022-11-08 |
2025-07-04 |
페인스 테라퓨틱스 인코포레이티드 |
항-5t4 항체 및 이의 용도
|
|
US12534540B2
(en)
*
|
2023-01-23 |
2026-01-27 |
Clemson University Research Foundation |
CYP1A1-targeted monoclonal antibody with reactivity across vertebrate taxa
|
|
WO2024159174A1
(en)
*
|
2023-01-27 |
2024-08-02 |
The United States Goverment As Represented By The Department Of Veterans Affairs |
Compositions for treating tauopathies and methods of use thereof
|
|
EP4673476A1
(en)
*
|
2023-02-28 |
2026-01-07 |
Mayo Foundation for Medical Education and Research |
Molecules that bind to b-cell activating factor receptor polypeptides
|
|
CN119306826B
(zh)
*
|
2023-07-11 |
2025-06-20 |
东莞市朋志生物科技有限公司 |
抗白介素-6抗体、检测白介素-6的试剂和试剂盒
|
|
WO2025044931A1
(zh)
*
|
2023-08-25 |
2025-03-06 |
康诺亚生物医药科技（成都）有限公司 |
阿尔茨海默病治疗剂的开发和应用
|
|
CN119613538B
(zh)
*
|
2024-12-12 |
2025-10-17 |
浙江大学医学院附属第一医院(浙江省第一医院) |
抗h10亚型流感病毒血凝素蛋白中和性单克隆抗体1e10及其应用
|
|
CN120209138B
(zh)
*
|
2025-05-29 |
2025-10-03 |
杭州广科安德生物科技有限公司 |
Tff3、osm蛋白的抗体及其组合和在结直肠癌诊断中的应用
|